Harvard Bioscience (HBIO) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.05% |
| Dec 31, 2025 | -42.36% |
| Sep 30, 2025 | 4.33% |
| Jun 30, 2025 | -21.03% |
| Mar 31, 2025 | -62.66% |
| Dec 31, 2024 | 43.19% |
| Sep 30, 2024 | -10.93% |
| Jun 30, 2024 | -23.71% |
| Mar 31, 2024 | -20.11% |
| Dec 31, 2023 | -92.61% |
| Sep 30, 2023 | 9.15% |
| Jun 30, 2023 | -2.36% |
| Mar 31, 2023 | 17.40% |
| Dec 31, 2022 | -13.43% |
| Sep 30, 2022 | -47.84% |
| Jun 30, 2022 | 46.17% |
| Mar 31, 2022 | -56.40% |
| Dec 31, 2021 | 25.75% |
| Sep 30, 2021 | 15.45% |
| Jun 30, 2021 | 3.80% |
| Mar 31, 2021 | -9.08% |
| Dec 31, 2020 | -11.29% |
| Sep 30, 2020 | -5.24% |
| Jun 30, 2020 | -15.24% |
| Mar 31, 2020 | -20.39% |
| Dec 31, 2019 | -39.12% |
| Sep 30, 2019 | -36.83% |
| Jun 30, 2019 | -23.66% |
| Mar 31, 2019 | -30.33% |
| Dec 31, 2018 | 15.27% |
| Sep 30, 2018 | -78.68% |
| Jun 30, 2018 | -45.35% |
| Mar 31, 2018 | -44.32% |
| Dec 31, 2017 | -17.49% |
| Sep 30, 2017 | -21.78% |
| Jun 30, 2017 | -18.39% |
| Mar 31, 2017 | -19.60% |
| Dec 31, 2016 | -24.60% |
| Sep 30, 2016 | -49.46% |
| Jun 30, 2016 | -18.97% |
| Mar 31, 2016 | -17.76% |
| Dec 31, 2015 | 40.10% |
| Sep 30, 2015 | -21.99% |
| Jun 30, 2015 | -16.77% |